Evaluation of Efficacy, Biodistribution, and Inflammation for a Potent siRNA Nanoparticle: Effect of Dexamethasone Co-treatment
Marc Abrams(Dicerna Pharmaceuticals (United States)), Laura Sepp‐Lorenzino(Intellia Therapeutics (United States)), Xianzhi Mao(United States Military Academy), Paul A. Burke(United States Military Academy), Steven M. Stirdivant(United States Military Academy), Vasant Jadhav(Alnylam Pharmaceuticals (United States)), Martha A. DiPietro(United States Military Academy), Stephanie Williams(United States Military Academy), Joseph P. Davide(United States Military Academy), Weimin Wang, Andrew W. Shaw(United States Military Academy), Jessica Seitzer(Intellia Therapeutics (United States)), Alan B. Sachs(United States Military Academy), Martin L. Koser(United States Military Academy)
Cited by 209
Related Papers
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
|New England Journal of Medicine|2021|1.7k
Total Synthesis of Spirotryprostatin A, Leading to the Discovery of Some Biologically Promising Analogues
|Journal of the American Chemical Society|1999|463
Pharmacologic shifting of a balance between protein refolding and degradation mediated by Hsp90
|Proceedings of the National Academy of Sciences|1996|409
A peptidomimetic inhibitor of farnesyl:protein transferase blocks the anchorage-dependent and -independent growth of human tumor cell lines.
|PubMed|1995|385
Micro RNA 145 Targets the Insulin Receptor Substrate-1 and Inhibits the Growth of Colon Cancer Cells
|Journal of Biological Chemistry|2007|356